NAD+
$60.00
500mg of reagent-grade NAD+
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells, functioning as a critical electron carrier in redox reactions and cellular energy metabolism. It is extensively studied in aging research, longevity biology, and metabolic investigations for its role in mitochondrial function, sirtuin pathway activation, and DNA repair mechanisms. NAD+ concentrations decline with age in preclinical models, making it a valuable tool for investigating cellular senescence pathways and age-related metabolic changes in laboratory settings.
Third Party Verified
500 MG – NDLY809 – 08/23/2025 – SAMPLE A
500 MG – ND601A – 08/23/2025 – SAMPLE B
Description
NAD+ (Nicotinamide Adenine Dinucleotide)
⚠️ LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR ANIMAL CONSUMPTION
This product is intended exclusively for in vitro research and analytical applications in professional laboratory settings. NOT approved by FDA for human use. NOT for clinical, diagnostic, or therapeutic purposes.
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells, functioning as a critical electron carrier in redox reactions and cellular energy metabolism. It is extensively studied in aging research, longevity biology, and metabolic investigations for its role in mitochondrial function, sirtuin pathway activation, and DNA repair mechanisms. NAD+ concentrations decline with age in preclinical models, making it a valuable tool for investigating cellular senescence pathways and age-related metabolic changes in laboratory settings.
Product Summary — NAD+ 500MG
| Product Name | NAD+ (Nicotinamide Adenine Dinucleotide) |
| Category | Coenzyme; investigational compound studied in aging and metabolic research |
| Molecular Formula | C₂₁H₂₇N₇O₁₄P₂ |
| Molecular Weight | ~663.5 g/mol |
| Structure | Dinucleotide consisting of a nicotinamide group and an adenine nucleotide joined by phosphodiester bonds |
| Form & Purity | Lyophilized powder; ≥98% purity (HPLC-verified) |
| Storage | Store lyophilized at −20 °C to −80 °C, dry, and protected from light. Reconstituted solutions should be stored short-term at 4 °C. Avoid repeated freeze–thaw cycles. |
| Key Research Areas | – Electron transport chain and mitochondrial bioenergetics – Sirtuin (SIRT1–SIRT7) activation and deacetylase activity – PARP-mediated DNA repair pathways – Oxidative phosphorylation and glycolytic flux – Redox homeostasis and ROS modulation in preclinical models |
| Research Use Cases | – Cellular senescence and aging pathway investigations – Mitochondrial function and biogenesis studies – NAD+ biosynthesis and salvage pathway characterization – Sirtuin-dependent gene regulation assays – Neurodegenerative disease modeling (in vitro) – Metabolic flux analysis in cell culture systems |
| Compliance | For research use only. Not FDA/EMA approved for medical use. Not for human consumption, clinical, diagnostic, or therapeutic purposes. |
Mechanism of Action of NAD+
Cellular Energy Metabolism
NAD+ functions as a critical coenzyme in oxidative phosphorylation and glycolysis, serving as an electron acceptor in catabolic reactions. In the mitochondrial electron transport chain, NAD+ is reduced to NADH at Complex I, facilitating the proton gradient that drives ATP synthase. This redox cycling is fundamental to cellular bioenergetics and is a primary focus of metabolic research.
Sirtuin Activation and Epigenetic Regulation
NAD+ serves as an obligate co-substrate for sirtuins (SIRT1–SIRT7), a family of NAD+-dependent deacetylases and ADP-ribosyltransferases. In preclinical models, sirtuin activation has been associated with regulation of inflammatory gene expression, maintenance of genomic stability, and modulation of cellular stress responses. These pathways are actively investigated in aging and longevity research.
DNA Repair and Genomic Integrity
NAD+ is consumed by poly(ADP-ribose) polymerases (PARPs) during DNA damage response. PARP1 and PARP2 utilize NAD+ to synthesize poly(ADP-ribose) chains at sites of DNA strand breaks, recruiting repair machinery. The competition between PARPs and sirtuins for the cellular NAD+ pool is a key area of investigation in geroscience research.
Redox Homeostasis
The NAD+/NADH ratio serves as a critical indicator of cellular redox state. In preclinical studies, perturbations in this ratio have been associated with altered mitochondrial membrane potential, increased reactive oxygen species (ROS) production, and shifts in metabolic substrate utilization. These observations make NAD+ a valuable research tool for studying oxidative stress pathways.
NAD+ Decline in Preclinical Aging Models
Published literature documents age-associated decline in tissue NAD+ levels across multiple preclinical model organisms. This decline has been correlated with reduced sirtuin activity, impaired mitochondrial function, and accumulation of DNA damage in laboratory studies. These findings have made NAD+ metabolism a central topic in biogerontology research.
Research Applications
- In vitro studies: NAD+ quantification assays, sirtuin activity measurements, PARP activation analysis, and mitochondrial respiration studies using Seahorse or Clark-type electrodes.
- Cell culture: NAD+ supplementation studies in primary cell cultures and immortalized cell lines to investigate dose-dependent effects on NAD+-consuming enzymes.
- Metabolic research: Isotope tracer studies for NAD+ biosynthesis pathway characterization, including de novo, Preiss–Handler, and salvage pathways.
- Aging research: Cellular senescence assays, SA-β-galactosidase staining, telomere length analysis, and senescence-associated secretory phenotype (SASP) profiling.
Citations
Imai, S.-I., & Guarente, L. (2014). NAD+ and Sirtuins in Aging and Disease. Trends in Cell Biology, 24(8), 464–471. https://doi.org/10.1016/j.tcb.2014.04.002
Braidy, N., & Alam, S. (2018). NAD+ in Brain Aging and Neurodegenerative Diseases. Current Topics in Medicinal Chemistry, 18(4), 284–294.
Cantó, C., Menzies, K. J., & Auwerx, J. (2015). NAD+ Metabolism and the Control of Energy Homeostasis. Cell Metabolism, 22(1), 31–53. https://doi.org/10.1016/j.cmet.2015.05.001
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513–528. https://doi.org/10.1016/j.cmet.2017.11.002
Explore our complete catalog of high-purity, third-party tested research compounds by visiting our main shop page for all your laboratory needs.
Third Party Verified
500 MG – NDLY809 – 08/23/2025 – SAMPLE A













Reviews
There are no reviews yet.